← Open Payments lookup

NACHOLE BROWN: Open Payments

NPI 1801576053 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,222 in 59 payments from 16 companies in 2025. Trend: 2023 $88 · 2024 $1,540 · 2025 $2,222

Food & beverage: $2,138Education: $84
CompanyPaymentsAmount
ABBVIE INC.15$698
Janssen Biotech, Inc.7$443
GENZYME CORPORATION5$244
Takeda Pharmaceuticals U.S.A., Inc.7$200
PFIZER INC.8$159
Phathom Pharmaceuticals, Inc.2$142
Madrigal Pharmaceuticals3$93
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$73
Ardelyx, Inc.2$39
Lilly USA, LLC1$26

Products named: TREMFYA, SKYRIZI, DUPIXENT, ENTYVIO, CREON, VOQUEZNA, LINZESS, VELSIPITY.

Industry payments across WA — which companies pay providers there.